Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Caroline Favron-Godbout, Eric Racine

    Journal International De Bioethique Et D'Ethique Des Sciences
    |March 30, 2023
    PubMed
    Summary
    This summary is machine-generated.

    Medical assistance in dying (MAiD) for amyotrophic lateral sclerosis (ALS) presents moral challenges. Widening MAiD eligibility may only partially resolve these issues, particularly those concerning the choice of how to die.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A Living Ethics Project to Address Inappropriate Levels of Care: Process and Outcomes.

    Journal of bioethical inquiry·2026
    Same author

    Understanding clinical ethics situations: a co-created repertoire of practices.

    BMC medical ethics·2026
    Same author

    A Living Ethics Project to Address Psychological Distress in Chronic Illness: Process and Outcomes.

    Health expectations : an international journal of public participation in health care and health policy·2025
    Same author

    Open-ended eudemonism in healthcare: epistemological and procedural challenges.

    Medicine, health care, and philosophy·2025
    Same author

    It's a Neurodiverse World: Stories from Neurodivergent People.

    Narrative inquiry in bioethics·2025
    Same author

    Envisioning a Living Ethics Approach to the Allocation of Scarce Resources.

    The American journal of bioethics : AJOB·2025
    Same journal

    Journal international de bioethique et d'ethique des sciences·2026
    Same journal

    Journal international de bioethique et d'ethique des sciences·2026
    Same journal

    Journal international de bioethique et d'ethique des sciences·2026
    Same journal

    Journal international de bioethique et d'ethique des sciences·2026
    Same journal

    Journal international de bioethique et d'ethique des sciences·2026
    Same journal

    Chapter 4. Neurotechnologies: striking a balance between scientific progress and privacy

    Journal international de bioethique et d'ethique des sciences·2026
    See all related articles

    Area of Science:

    • Neuroscience
    • Medical Ethics
    • Palliative Care

    Background:

    • Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease.
    • Some individuals with ALS consider medical assistance in dying (MAiD) due to the disease's impact.
    • Existing MAiD eligibility criteria may not fully address the complex ethical landscape for ALS patients.

    Approach:

    • A critical literature review was conducted using MEDLINE, EMBASE, CINAHL, and Web of Science.
    • Searches focused on ethics, MAiD, and ALS, yielding 41 relevant articles.
    • Thematic content analysis identified moral issues within three categories: disease experience, end-of-life choices, and MAiD implementation.

    Key Points:

    • Moral issues in ALS and MAiD arise from the disease experience, the choice of death, and MAiD implementation.

    Related Experiment Videos

  • Stakeholder perspectives on ALS and MAiD differ, leading to potential disagreements but also shared views.
  • Widening MAiD eligibility primarily addresses moral concerns related to the method of dying.
  • Conclusions:

    • Widening MAiD eligibility offers a partial solution to the moral challenges faced by people with ALS.
    • A comprehensive approach is needed to address the full spectrum of ethical issues, considering diverse stakeholder viewpoints.
    • Further research should explore the nuanced ethical considerations surrounding MAiD for individuals with progressive neurodegenerative conditions like ALS.